SEC 13F Intelligence

Managers / Q1 2024 · view latest →

Farrow Financial, Inc.

CIK 0002010644 · 1 KENNEDY DRIVE SUITE U8, SOUTH BURLINGTON, VT, 05403 · 8027284287

Reported Value
$143M
Q1 2024
Positions
53
Filings on Record
10
2019–present window
Filed
May 2, 2024
original filing

Summary

Farrow Financial, Inc. reported $143M in U.S.-listed holdings across 53 positions for Q1 2024.

The portfolio is heavily concentrated: ITOT alone accounts for 27.1% of reported value.

Compared with Q4 2023, the fund opened 2 new positions and exited 0.

Portfolio Metrics

Turnover
+3.0%
vs prior filed quarter
Top-10 Concentration
+59.9%
share of reported value
Largest Position
+27.1%
Ishares Tr

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’23: $133MQ4 ’23Q1 ’24: $143MQ2 ’24: $147MQ2 ’24Q3 ’24: $159MQ4 ’24: $154MQ4 ’24Q1 ’25: $149MQ2 ’25: $165MQ2 ’25Q3 ’25: $172MQ4 ’25: $174MQ4 ’25Q1 ’26: $176Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 51.6%ETP: 46.4%REIT: 2.0%
  • Common Stock · 51.6% · $74M
  • ETP · 46.4% · $66M
  • REIT · 2.0% · $3M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
FIWFIRST TR EXCHANGE TRADED FDNEW+21.6K21.6K+$2M$2M
BOTZGLOBAL X FDSNEW+55.4K55.4K+$2M$2M
NVDANVIDIA CORPORATIONTRIMMED−2.9K4.7K+$475,623$4M
LCTXLINEAGE CELL THERAPEUTICS INTRIMMED−5.5K11.5K−$1,510$17,020
ICSHISHARES TRADDED+20.3K89.0K+$1M$5M
NRGNRG ENERGY INCTRIMMED−9.9K31.2K−$12,121$2M
LECOLINCOLN ELEC HLDGS INCTRIMMED−2.1K8.2K−$145,986$2M
TDOCTELADOC HEALTH INCADDED+13.5K91.6K−$299,384$1M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2024

45 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1ITOTISHARES TRCORE S&P TTL STK · MSCI USA ESG SLC · MSCI INTL VLU FT · BLACKROCK ULTRA · CORE MSCI EAFE27.14%$39M612.8K
2AAPLAPPLE INChistory →COM7.83%$11M65.1K
3MOATVANECK ETF TRUSThistory →MRNGSTR WDE MOAT6.48%$9M102.7K
4BUGGLOBAL X FDSCYBRSCURTY ETF · RBTCS ARTFL INTE · CONSCIOUS COS3.14%$4M144.8K
5SPYDSPDR SER TRPRTFLO S&P500 HI · SPDR S&P 500 ETF · PORTFOLIO S&P4003.02%$4M102.0K
6NVDANVIDIA CORPORATIONhistory →COM2.97%$4M4.7K
7DIVOAMPLIFY ETF TRhistory →CWP ENHANCED DIV2.95%$4M108.1K
8BMIBADGER METER INChistory →COM2.27%$3M20.0K
9MSFTMICROSOFT CORPhistory →COM2.20%$3M7.5K
10INTCINTEL CORPhistory →COM1.96%$3M63.3K
11MTZMASTEC INChistory →COM1.96%$3M30.0K
12VMCVULCAN MATLS COhistory →COM1.95%$3M10.2K
13CWCOCONSOLIDATED WATER CO INChistory →ORD1.85%$3M90.0K
14TRMBTRIMBLE INChistory →COM1.74%$2M38.5K
15TTEKTETRA TECH INC NEWhistory →COM1.56%$2M12.0K
16FIWFIRST TR EXCHANGE TRADED FDhistory →WTR ETF1.54%$2M21.6K
17JPMJPMORGAN CHASE & COhistory →COM1.52%$2M10.8K
18BLACKROCK INCCOM1.49%$2M2.5K
19NRGNRG ENERGY INChistory →COM NEW1.48%$2M31.2K
20NEENEXTERA ENERGY INChistory →COM1.47%$2M32.9K
21LECOLINCOLN ELEC HLDGS INChistory →COM1.47%$2M8.2K
22CNICANADIAN NATL RY COhistory →COM1.46%$2M15.8K
23JNJJOHNSON & JOHNSONhistory →COM1.45%$2M13.0K
24TECKTECK RESOURCES LTDhistory →CL B1.42%$2M44.4K
25PLXSPLEXUS CORPhistory →COM1.42%$2M21.4K
26CNQCANADIAN NAT RES LTDhistory →COM1.42%$2M26.5K
27DGXQUEST DIAGNOSTICS INChistory →COM1.41%$2M15.1K
28CSCOCISCO SYS INChistory →COM1.38%$2M39.4K
29LLYELI LILLY & COhistory →COM1.34%$2M2.5K
30ZTSZOETIS INChistory →CL A1.33%$2M11.2K
31MDYSPDR S&P MIDCAP 400 ETF TRhistory →UTSER1 S&PDCRP1.30%$2M3.3K
32SUISUN CMNTYS INChistory →COM1.02%$1M11.3K
33ELSEQUITY LIFESTYLE PPTYS INCCOM0.99%$1M21.9K
34TDOCTELADOC HEALTH INCCOM0.97%$1M91.6K
35ABNBAIRBNB INCCOM CL A0.82%$1M7.1K
36CRSPCRISPR THERAPEUTICS AGNAMEN AKT0.81%$1M17.0K
37PGPROCTER AND GAMBLE COCOM0.70%$994,4316.1K
38ALBALBEMARLE CORPCOM0.61%$873,7006.6K
39SCHBSCHWAB STRATEGIC TRUS BRD MKT ETF0.56%$804,70113.2K
40ITWILLINOIS TOOL WKS INCCOM0.55%$791,0372.9K
41BRK/BBERKSHIRE HATHAWAY INC DELCL B NEW0.46%$651,8061.6K
42SPYSPDR S&P 500 ETF TRTR UNIT0.28%$394,395754
43RFREGIONS FINANCIAL CORP NEWCOM0.16%$223,02410.6K
44NKENIKE INCCL B0.15%$216,1542.3K
45LCTXLINEAGE CELL THERAPEUTICS INCOM0.01%$17,02011.5K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$176M53May 1, 202613F-HRchanges · EDGAR ↗
Q4 2025$174M53Jan 27, 202613F-HRchanges · EDGAR ↗
Q3 2025$172M53Nov 3, 202513F-HRchanges · EDGAR ↗
Q2 2025$165M51Aug 11, 202513F-HRchanges · EDGAR ↗
Q1 2025$149M50May 9, 202513F-HRchanges · EDGAR ↗
Q4 2024$154M50Feb 7, 202513F-HRchanges · EDGAR ↗
Q3 2024$159M52Oct 24, 202413F-HRchanges · EDGAR ↗
Q2 2024$147M50Jul 15, 202413F-HRchanges · EDGAR ↗
Q1 2024$143M53May 2, 202413F-HRchanges · EDGAR ↗
Q4 2023$133M51Feb 8, 202413F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.